Multiple sclerosis and familial mediterranean fever: A case report;Sclérose en plaques et fièvre méditerranéenne familiale : un cas et revue de la littérature

Revue Neurologique

Volumn 164, Issue 11, 2008, Pages 943-947

  Guinet, A ^a   Grateau, G ^b   Nifle, C ^a   Rozier, A ^c   Pico, F ^a  

^a CENTRE HOSPITALIER DE VERSAILLES   (France)

^b HÔPITAL TENON   (France)

^c Hopital Prive de l'Ouest Parisien   (France)

Author keywords

Familial Mediterranean fever; Multiple sclerosis; Neuro Beh et's syndrome

Indexed keywords

BETA1A INTERFERON; COLCHICINE; CORTICOSTEROID;

ADULT; ANAMNESIS; ARTICLE; BEHCET DISEASE; CANKER; CASE REPORT; CLINICAL FEATURE; FAMILIAL MEDITERRANEAN FEVER; HUMAN; LABORATORY TEST; MALE; MULTIPLE SCLEROSIS; NUCLEAR MAGNETIC RESONANCE IMAGING; TURKEY (REPUBLIC); BRAIN; DIPLOPIA; PATHOLOGY;

ADULT; BRAIN; COLCHICINE; DIPLOPIA; FAMILIAL MEDITERRANEAN FEVER; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; MULTIPLE SCLEROSIS;

EID: 60749102200     PISSN: 00353787     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neurol.2008.04.004     Document Type: Article

References (21)

1. Akman-Demir G., Gul A., Gurol E., et al. Inflammatory/demyelinating central nervous system involvement in familial Mediterranean fever (FMF): coincidence or association?. J. Neurol. 253 (2006) 928-934
2. Alter M., Leibowitz U., and Speer J. Risk of multiple sclerosis related to age at immigration to Israel. Arch. Neurol. 15 (1966) 234-237
3. Barkhof F., Filippi M., Miller D., et al. Comparison of MRI criteria at first presentation to predict conversion to clinically definite multiple sclerosis. Brain 120 (2007) 2059-2069
4. B'Chir Hamzaoui S., Bouslama K., Abdallah M., M'Rad R., M'Rad S., and Ben Dridi M. Myalgia in familial Mediterranean fever. Rev. Neurol. (Paris) 163 (2007) 93-95
5. Ben-Chetrit E., Cohen R., and Chajek-Shaul T. Familial mediterranean fever and Behçet's disease - are they associated?. J. Rheumatol. 29 (2002) 530-534
6. Bernstein C.N., Wajda A., and Blanchard J.F. The clustering of other chronic inflammatory diseases in inflammatory bowel disease: A population-based study. Gastroenterology 129 (2005) 827-836
7. Chae J.J., Wood G., Masters S.L., et al. The B30.2 domain of pyrin, the familial Mediterranean fever protein, interacts directly with caspase-1 to modulate IL-1beta production. Proc. Natl. Acad. Sci. 103 (2006) 9982-9987
8. Gedalia A., and Zamir S. Neurologic manifestations in familial Mediterranean fever. Pediatr. Neurol. 9 (1993) 301-302
9. Gupta G., Gelfand J.M., and Lewis J.D. Increased risk for demyelinating diseases in patients with inflammatory bowel disease. Gastroenterology 129 (2005) 819-826
10. Hafler D.A., Compston A., Sawcer S., et al. Risk alleles for multiple sclerosis identified by a genomewide study. N. Engl. J. Med. 357 (2007) 851-862
11. Hentgen V., and Grateau G. Fièvres récurrentes héréditaires. In: SAS E.E.-M. (Ed). Traité de médecine Akos. Vol5-0375 (2007)
12. Ishak G.E., Khoury N.J., Birjawi G.A., El-Zein Y.R., Naffaa L.N., and Haddad M.C. Imaging findings of familial Mediterranean fever. Clin. Imaging 30 (2006) 153-159
13. Jenne D.E., Aries P.M., Einwachter S., et al. The low-penetrance R92Q mutation of the tumour necrosis factor superfamily 1A gene is neither a major risk factor for Wegener's granulomatosis nor multiple sclerosis. Ann. Rheum. Dis. 66 (2007) 1266-1267
14. Kumpfel T., Hoffmann L.A., Rubsamen H., et al. Late-onset tumor necrosis factor receptor-associated periodic syndrome in multiple sclerosis patients carrying the TNFRSF1A R92Q mutation. Arthritis Rheum. 56 (2007) 2774-2783
15. Papin S., Cuenin S., Agostini L., et al. The SPRY domain of Pyrin, mutated in familial Mediterranean fever patients, interacts with inflammasome components and inhibits proIL-1beta processing. Cell Death Differ. 14 (2007) 1457-1466
16. Shinar Y., Livneh A., Villa Y., et al. Common mutations in the familial Mediterranean fever gene associate with rapid progression to disability in non-Ashkenazi Jewish multiple sclerosis patients. Genes Immun. 4 (2003) 197-203
17. Topcuoglu M.A., and Karabudak R. Familial Mediterranean fever and multiple sclerosis. J. Neurol. 244 (1997) 510-514
18. Tunca M., Akar S., Soyturk M., et al. The effect of interferon alpha administration on acute attacks of familial Mediterranean fever: a double-blind, placebo-controlled trial. Clin. Exp. Rheumatol. 22 (2004) S37-S40
19. Vinceneux P. Maladie périodique. Atteintes neurologiques au cours des maladies systémiques (2003), Flammarion, Paris, France p. 309-311
20. McDonald W.I., Compston A., Edan G., et al. Recommended diagnostic criteria for multiple sclerosis: guidelines from the international panel on the diagnosis of multiple sclerosis. Annals of Neurology 50 (2001) 121-127
21. Yucesan C., Canyigit A., and Turkcapar N. The coexistence of familial Mediterranean fever with multiple sclerosis. Eur. J. Neurol. 11 (2004) 716-717